UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 30, 2024

 

OR

 

 

 

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ________________ to _______________

 

Commission File Number 001-35383

 

THE EASTERN COMPANY

(Exact name of registrant as specified in its charter)

 

Connecticut

 

06-0330020

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

3 Enterprise Drive, Suite 408, Shelton, Connecticut

 

06484

(Address of principal executive offices)

 

(Zip Code)

 

(203)-729-2255

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, No Par Value

EML

NASDAQ Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes      No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

 

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes      No

 

As of March 30, 2024, 6,233,510 shares of the registrant’s common stock, no par value per share, were issued and outstanding.

 

 

 

 

The Eastern Company

Form 10-Q

 

FOR THE QUARTERLY PERIOD ENDED MARCH 30, 2024

 

TABLE OF CONTENTS

 

 

 

Page

PART I

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

3

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

24

 

 

 

Item 4.

Controls and Procedures

24

 

 

 

PART II

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

25

 

 

 

Item 1A.

Risk Factors

25

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

25

 

 

 

Item 3.

Defaults Upon Senior Securities

25

 

 

 

Item 4.

Mine Safety Disclosures

26.

 

 

 

Item 5.

Other Information

25

 

 

 

Item 6

Exhibits

26

 

 

 

 

Signatures

27

 

 
2

Table of Contents

 

PART 1 – FINANCIAL INFORMATION

 

ITEM 1 – FINANCIAL STATEMENTS

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Net sales

 

$67,929,087

 

 

$72,495,367

 

Cost of products sold

 

 

(51,732,988)

 

 

(56,997,668)

Gross margin

 

 

16,196,099

 

 

 

15,497,699

 

 

 

 

 

 

 

 

 

 

Product development expense

 

 

(1,359,797)

 

 

(1,401,199)

Selling and administrative expenses

 

 

(11,498,958)

 

 

(11,937,637)

Operating profit

 

 

3,337,344

 

 

 

2,158,863

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

(845,035)

 

 

(726,006)

Other income (expense)

 

 

10,354

 

 

 

(630,699)

Income before income taxes

 

 

2,502,663

 

 

 

802,158

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(555,091)

 

 

(194,845)

Net income

 

$1,947,572

 

 

$607,313

 

 

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

 

Basic

 

$0.31

 

 

$0.10

 

 

 

 

 

 

 

 

 

 

Diluted

 

$0.31

 

 

$0.10

 

 

 

 

 

 

 

 

 

 

Cash dividends per share:

 

$0.11

 

 

$0.11

 

 

 

 

 

 

 

 

 

 

See accompanying notes.

 

 
3

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Net income

 

$1,947,572

 

 

$607,313

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in foreign currency translation

 

 

(157,000)

 

 

336,585

 

 

 

 

 

 

 

 

 

 

Change in fair value of foreign currency swap, net of tax cost (benefit) of:

 

 

 

 

 

 

 

 

2024 - $96,724; 2023 - $(87,691)

 

 

403,016

 

 

 

(277,687)

 

 

 

 

 

 

 

 

 

Change in pension and postretirement benefit costs, net of taxes of:

 

 

 

 

 

 

 

 

2024 - $71,355; 2023 - $74,360

 

 

243,336

 

 

 

252,668

 

Total other comprehensive income

 

 

489,352

 

 

 

311,566

 

Comprehensive income

 

$2,436,924

 

 

$918,879

 

 

 

 

 

 

 

 

 

 

See accompanying notes.

 

 
4

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

 

Current Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$7,356,444

 

 

$8,299,453

 

Marketable Securities

 

 

2,127,735

 

 

 

986,477

 

Accounts receivable, less allowances: 2024 - $541,103; 2023 - $564,816

 

 

42,881,758

 

 

 

37,057,488

 

Inventories

 

 

55,847,071

 

 

 

59,272,207

 

Current portion of notes receivable

 

 

618,231

 

 

 

573,269

 

Prepaid expenses and other assets

 

 

6,199,897

 

 

 

6,047,814

 

Total Current Assets

 

 

115,031,136

 

 

 

112,236,708

 

 

 

 

 

 

 

 

 

 

Property, Plant and Equipment

 

 

61,842,148

 

 

 

60,270,096

 

Accumulated depreciation

 

 

(32,710,475)

 

 

(31,980,335)

Property, Plant and Equipment, Net

 

 

29,131,673

 

 

 

28,289,761

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

70,722,962

 

 

 

70,776,893

 

Trademarks

 

 

5,514,884

 

 

 

5,514,960

 

Patents and other intangibles net of accumulated amortization

 

 

14,360,192

 

 

 

15,325,927

 

Long term notes receivable, less current portion

 

 

329,970

 

 

 

374,932

 

Deferred Income Taxes

 

 

2,283,571

 

 

 

2,283,571

 

Right of Use Assets

 

 

16,521,127

 

 

 

17,236,449

 

Total Other Assets

 

 

109,732,706

 

 

 

111,512,732

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$253,895,515

 

 

$252,039,201

 

 

 

 

 

 

 

 

 

 

See accompanying notes.

 

 
5

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

(unaudited)

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

Accounts payable

 

$26,971,547

 

 

$25,319,473

 

Accrued compensation

 

 

4,636,088

 

 

 

5,379,381

 

Other accrued expenses

 

 

4,874,024

 

 

 

4,556,623

 

Current portion of operating lease liability

 

 

4,195,865

 

 

 

4,424,369

 

Current portion of finance lease liability

 

 

182,290

 

 

 

182,010

 

Current portion of long-term debt

 

 

2,871,870

 

 

 

2,871,870

 

Total Current Liabilities

 

 

43,731,684

 

 

 

42,733,726

 

 

 

 

 

 

 

 

 

 

Other long-term liabilities

 

 

640,724

 

 

 

640,724

 

Operating lease liability, less current portion

 

 

12,325,261

 

 

 

12,812,079

 

Finance lease liability, less current portion

 

 

696,584

 

 

 

728,100

 

Long-term debt, less current portion

 

 

40,271,398

 

 

 

41,063,865

 

Accrued postretirement benefits

 

 

565,727

 

 

 

554,758

 

Accrued pension cost

 

 

21,150,758

 

 

 

21,025,365

 

Total Liabilities

 

 

119,382,136

 

 

 

119,558,617

 

 

 

 

 

 

 

 

 

 

Shareholders’ Equity

 

 

 

 

 

 

 

 

Voting Preferred Stock, no par value:

 

 

 

 

 

 

 

 

Authorized and unissued: 1,000,000 shares

 

 

 

 

 

 

 

 

Nonvoting Preferred Stock, no par value:

 

 

 

 

 

 

 

 

Authorized and unissued: 1,000,000 shares

 

 

 

 

 

 

 

 

Common Stock, no par value, Authorized: 50,000,000 shares

 

 

34,464,595

 

 

 

33,950,859

 

Issued: 9,118,031 shares as of 2024 and 9,091,815 shares as of 2023

 

 

 

 

 

 

 

 

Outstanding: 6,233,510 shares as of 2024 and 6,217,370 shares as of 2023

 

 

 

 

 

 

 

 

Treasury Stock: 2,884,521 shares as of 2024 and 2,874,445 shares as of 2023

 

 

(23,515,267)

 

 

(23,280,467)

Retained earnings

 

 

146,069,675

 

 

 

144,805,168

 

Accumulated other comprehensive loss:

 

 

 

 

 

 

 

 

Foreign currency translation

 

 

(1,023,599)

 

 

(866,599)

Unrealized gain on foreign currency swap, net of tax

 

 

403,016

 

 

 

-

 

Unrecognized net pension and postretirement benefit costs, net of tax

 

 

(21,885,041)

 

 

(22,128,377)

Accumulated other comprehensive loss

 

 

(22,505,624)

 

 

(22,994,976)

Total Shareholders’ Equity

 

 

134,513,379

 

 

 

132,480,584

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$253,895,515

 

 

$252,039,201

 

 

 

 

 

 

 

 

 

 

See accompanying notes.

 

 
6

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Operating Activities

 

 

 

 

 

 

Net income

 

$1,947,572

 

 

$607,313

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

1,876,124

 

 

 

1,814,749

 

Reduction in carrying amount of ROU assets

 

 

715,322

 

 

 

631,368

 

Unrecognized pension and postretirement benefits

 

 

445,218

 

 

 

880,421

 

Loss on sale of equipment and other assets

 

 

37,330

 

 

 

-

 

Provision for doubtful accounts

 

 

(23,000)

 

 

3,269

 

Stock compensation expense (benefit)

 

 

513,737

 

 

 

(49,246)

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(5,898,945)

 

 

(1,585,976)

Inventories

 

 

3,415,931

 

 

 

7,212,179

 

Prepaid expenses and other

 

 

(109,507)

 

 

(37,330)

Other assets

 

 

21,710

 

 

 

(155,055)

Accounts payable

 

 

3,601,059

 

 

 

(1,031,704)

Accrued compensation

 

 

(1,000,332)

 

 

(1,104,186)

Change in operating lease liability

 

 

(715,322)

 

 

(639,987)

Other accrued expenses

 

 

(1,248,705)

 

 

314,443

 

Net cash provided by operating activities

 

 

3,578,192

 

 

 

6,860,258

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Marketable securities

 

 

(999,960)

 

 

-

 

Payments received from notes receivable

 

 

-

 

 

 

2,233,192

 

Proceeds from sale of equipment

 

 

18,000

 

 

 

-

 

Purchases of property, plant, and equipment

 

 

(1,776,954)

 

 

(1,151,205)

Net cash (used in) provided by investing activities

 

 

(2,758,914)

 

 

1,081,987

 

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Payments on short term borrowings (revolver)

 

 

-

 

 

 

(268,249)

Principal payments on long-term debt

 

 

(792,467)

 

 

(4,858,000)

Financing leases, net

 

 

(31,236)

 

 

723,254

 

Purchase common stock for treasury

 

 

(234,800)

 

 

-

 

Dividends paid

 

 

(683,065)

 

 

(684,293)

Net cash used in financing activities

 

 

(1,741,568)

 

 

(5,087,288)

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash

 

 

(20,719)

 

 

28,538

 

Net change in cash and cash equivalents

 

 

(943,009)

 

 

2,883,495

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

 

8,299,453

 

 

 

10,187,522

 

Cash and cash equivalents at end of period

 

$7,356,444

 

 

$13,071,017

 

 

 

 

 

 

 

 

 

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

 

 

Interest

 

$831,462

 

 

$716,763

 

Income taxes

 

 

230,523

 

 

 

(59,681)

 

 

 

 

 

 

 

 

 

Non-cash investing and financing activities

 

 

 

 

 

 

 

 

Right of use asset

 

 

140,939

 

 

 

(652,914)

Lease liability

 

 

(140,939)

 

 

(328,721)

 

 

 

 

 

 

 

 

 

See accompanying notes

 

 
7

Table of Contents

 

THE EASTERN COMPANY AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

March 30, 2024

 

Note A – Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and do not include all the information and footnotes required by generally accepted accounting principles in the United States (“GAAP”) for complete financial statements. Refer to the consolidated financial statements of The Eastern Company (together with its consolidated subsidiaries, the “Company,” “we,” “us” or “our”) and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2023, filed with the Securities and Exchange Commission on March 12, 2024 (the “2023 Form 10-K”), for additional information.

 

The accompanying condensed consolidated financial statements are unaudited. However, in the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the results of operations for interim periods have been reflected therein. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year. All intercompany accounts and transactions are eliminated.

 

The condensed consolidated balance sheet as of December 30, 2023 has been derived from the audited consolidated balance sheet at that date.

 

The Company’s fiscal year is a 52-53-week fiscal year ending on the Saturday nearest to December 31. References to 2023, the 2023 fiscal year or fiscal 2023 mean the 52-week period ended on December 30, 2023, and references to 2024, the 2024 fiscal year or fiscal 2024 mean the 52-week period ending on December 28, 2024. In a 52-week fiscal year, each quarter has 13 weeks. References to the first quarter of 2023, the first fiscal quarter of 2023, the first quarter of fiscal 2023 or the three months ended April 1, 2023, mean the period from January 1, 2023 to April 1, 2023. References to the first quarter of 2024, the first fiscal quarter of 2024, the first fiscal quarter of 2024 or the three months ended March 30, 2024, mean the 13-week period from December 31, 2023 to March 30, 2024.

 

Certain amounts in the 2023 financial statements have been reclassified to conform with the 2024 presentation with no impact or change to previously reported net income or shareholders’ equity.

 

Note B – Earnings Per Share

 

The denominators used to calculate earnings per share are as follows:

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Basic:

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

Dilutive stock appreciation rights

 

 

39,727

 

 

 

10,962

 

Denominator for diluted earnings per share

 

 

6,255,400

 

 

 

6,233,989

 

 

 
8

Table of Contents

 

Note C – Fair Value of Instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The company utilizes a fair value hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The fair value hierarchy has three levels of inputs that may be used to measure fair value:

 

Level 1

Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

 

Level 2

Quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.

 

 

Level 3

Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable.

 

The Company’s financial instruments are primarily investments in marketable securities (Level 1) and pension assets, see Note L, Retirement Benefit Plans.

 

The carrying amounts of other financial instruments (cash and cash equivalents, marketable securities, accounts receivable, accounts payable and debt) as of March 30, 2024 and December 30, 2023, approximate fair value because of their short-term nature and market-based interest rates.

 

Note D – Inventories

 

Inventories consist of the following components:

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

 

 

 

 

 

Raw material and component parts

 

$23,084,312

 

 

$24,500,087

 

Work in process

 

 

9,381,683

 

 

 

9,957,068

 

Finished goods

 

 

23,381,076

 

 

 

24,815,052

 

Total inventories

 

$55,847,071

 

 

$59,272,207

 

 

Note E - Goodwill

 

The aggregate carrying amount of goodwill is approximately $70.7 million as of March 30, 2024. No impairment was recognized in the first quarter of 2024.

 

The Company evaluates its reporting units for impairment annually in December, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Such events and circumstances could include, among other things, increased competition or unexpected loss of market share, significant adverse changes in the markets in which the Company operates, or unexpected business disruptions. The Company tests reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its estimated fair value, the Company records an impairment loss based on the difference between fair value and carrying amount not to exceed the associated carrying amount of goodwill. Determining the fair value of a reporting unit involves the use of significant estimates and assumptions. The values assigned to the key assumptions represent management’s assessment of future trends in the relevant industry and have been based on historical data from both external and internal sources.

 

Note F – Leases

 

The Company presents right-of-use (ROU) assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases. The Company accounts for non-lease components as part of the lease component to which they relate. Lease accounting involves significant judgements, including making estimates related to the lease term, lease payments, and discount rate.

 

The Company has operating leases for buildings, warehouses, and office equipment. The Company determines whether an arrangement is, or contains, a lease at contract inception. An arrangement contains a lease if the Company has the right to direct the use of and obtain substantially all the economic benefits of an identified asset. ROU assets and lease liabilities are recognized at lease commencement based on the present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew. The exercise of lease renewal options is at our sole discretion. All options to extend, when it is reasonably certain the option will be exercised, have been included in the calculation of the ROU asset and lease liability.

 

 
9

Table of Contents

 

Currently, the Company has twenty-two operating leases with a lease liability of $16.5 million and two finance leases with a lease liability of $0.9 million as of March 30, 2024. The terms and conditions of the leases are determined by the individual agreements. The leases do not contain residual value guarantees, restrictions, or covenants that could cause the Company to incur additional financial obligations. There are no related party lease transactions. There are no leases that have not yet commenced that could create significant rights and obligations for the Company.

 

The future payments (in millions) due under non-cancelable operating and finance leases as of March 30, 2024 are as follows:

 

 

 

Operating

 

 

Finance

 

2024

 

$3.2

 

 

$0.1

 

2025

 

 

3.2

 

 

 

0.2

 

2026

 

 

2.5

 

 

 

0.2

 

2027 and thereafter

 

 

10.2

 

 

 

0.6

 

 

 

 

19.1

 

 

 

1.1

 

Less effects of discounting

 

 

(2.6)

 

 

(0.2)

Lease liabilities recognized

 

$16.5

 

 

$0.9

 

 

As of March 30, 2024, the weighted average lease term for all operating and finance leases is 7.0 and 5.8 years, respectively. The weighted average discount rate associated with operating and finance leases was 6.3% and 6.4%, respectively.

 

Note G - Debt

 

On June 16, 2023, the Company entered into a credit agreement with TD Bank, N.A., Wells Fargo Bank, Bank of America, and M&T Bank as lenders (the “Credit Agreement”), that included a $60 million term portion and a $30 million revolving commitment portion. The proceeds of the term loan were used to repay the Company’s remaining outstanding term loan and to terminate its existing credit facility with Santander Bank, N.A. (approximately $59 million). The term loan portion of the credit facility requires quarterly principal payments of (i) $750,000 beginning on September 30, 2023 through June 30, 2025, (ii) $1,125,000 beginning on September 30, 2025 through June 30, 2027, and (iii) $1,500,000 beginning on September 30, 2027 through March 31, 2028, with the balance of the term loan payable on the maturity date of June 16, 2028. Amounts outstanding under the revolving portion of the credit facility are generally due and payable on the expiration date of the Credit Agreement (June 16, 2028). The Company can elect to prepay some or all the outstanding balance from time to time without penalty. A commitment fee is payable on the unused portion of the revolving credit facility based on the Company’s consolidated ratio of net debt to adjusted EBITDA from time to time. Currently, the commitment fee is 0.30%. The Company has no borrowings outstanding under the revolving commitment portion of the credit facility as of March 30, 2024.

 

The term loan bears interest at a variable rate based on the term secured overnight financing rate (“SOFR”), plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, depending on the Company’s senior net leverage ratio. Borrowings under the revolving portion bear interest at a variable rate based on, at the Company’s election, a base rate plus an applicable margin of 0.875% to 1.625% or term SOFR, plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, with such margins determined based on the Company’s senior net leverage ratio. The Company’s obligations under the Credit Agreement are secured by a lien on certain of the Company’s and its subsidiaries’ assets pursuant to a Pledge and Security Agreement, dated as of June 16, 2023, with TD Bank N.A., as administrative agent.

 

The Company’s loan covenants under the Credit Agreement require the Company to maintain a senior net leverage ratio not to exceed 3.5 to 1. In addition, the Company is required to maintain a fixed charge coverage ratio to be not less than 1.25 to 1. The Company was in compliance with all its covenants under the Credit Agreement on March 30, 2024, and through the date of filing this Form 10-Q.

 

 
10

Table of Contents

 

Note H - Stock Options and Awards

 

On February 19, 2020, the Board of Directors of the Company (the “Board”) adopted the Eastern Company 2020 Stock Incentive Plan (the “2020 Plan”), which replaced The Eastern Company 2010 Executive Stock Incentive Plan after its expiration in February 2020. On April 29, 2020, at the Company’s 2020 Annual Meeting of Shareholders, the shareholders of the Company approved and adopted the 2020 Plan. The Company has no other existing plan pursuant to which equity awards may be granted.

 

Incentive stock options granted under the 2020 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock options are granted. Restricted stock awards may also be granted to participants under the 2020 Plan with restrictions determined by the Compensation Committee of the Board. Under the 2020 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Board.  The Company did not grant any stock awards during the first three months of fiscal 2024 and fiscal 2023. For the first three months of fiscal years 2024 and 2023, the Company used fair market value to determine the associated expense with stock awards.

 

The 2020 Plan also permits the issuance of Stock Appreciation Rights (“SARs”). The SARs are in the form of an option with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock. The Company did not issue any SARs during the first three months of fiscal 2024 and 2023.

 

Stock-based compensation expense (income), including forfeitures, in connection with SARs and stock awards previously granted to employees was approximately $434,000 and $(184,000) in the first quarter of 2024 and the first quarter of 2023, respectively.

 

As of March 30, 2024, there were 879,924 shares of Company common stock reserved and available for future grant under the 2020 Plan.

 

The following tables set forth the outstanding SARs for the period specified:

 

 

 

Three Months Ended

 

 

Year Ended

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

Outstanding at beginning of period

 

 

13,000

 

 

$24.19

 

 

 

146,166

 

 

$23.22

 

Expired

 

 

(9,000)

 

 

26.30

 

 

 

(50,833)

 

 

24.24

 

Exercised

 

 

-

 

 

 

-

 

 

 

(33,333)

 

 

21.10

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(49,000)

 

 

22.80

 

Outstanding at end of period

 

 

4,000

 

 

$

20.20

 

 

 

13,000

 

 

$

24.19

 

 

SARs Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

 

 

Range of Exercise Prices

 

 

Outstanding as

of March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted

Average

Exercise

Price

 

 

Exercisable

as of

March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

 

 
11

Table of Contents

 

The following tables set forth the outstanding stock awards for the period specified:

 

 

 

Three Months Ended

 

 

Year

Ended

 

 

 

March 30,

2024

 

 

December 30,

2023

 

 

 

Shares

 

 

Shares

 

Outstanding at beginning of period

 

 

89,400

 

 

 

64,500

 

Issued

 

 

-

 

 

 

82,800

 

Exercised

 

 

(23,734)

 

 

(10,600)

Forfeited

 

 

(1,433)

 

 

(47,300)

Outstanding at end of period

 

 

64,233

 

 

 

89,400

 

 

As of March 30, 2024, outstanding SARs and stock awards had an intrinsic value of $2,245,274.

 

Note I – Share Repurchase Program

 

On August 21, 2023, the Company announced that the Board of Directors of the Company had approved a new share repurchase program authorizing the Company to repurchase up to 200,000 shares of the Company’s common stock through August 20, 2028. The Company’s share repurchase program does not obligate it to acquire the Company’s common stock at any specific cost per share. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

 

Below is a summary of the Company’s shares repurchased during the first quarter of 2024 under the new share repurchase program.

 

Period

 

Total

Number

of Shares

Purchased

 

 

Average

Price Paid

Per Share

 

 

Total

Number

of Shares

Purchased

as Part of

Publicly

Announced

Plans or

Programs

 

 

Maximum

Number

of Shares

that may

yet be

Purchased

Under the

Plans or

Programs

 

Balance as of December 30, 2023

 

 

40,000

 

 

$18.39

 

 

 

40,000

 

 

 

160,000

 

December 31, 2024 – March 30, 2024

 

 

10,076

 

 

 

23.30

 

 

 

10,076

 

 

 

149,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 30, 2024

 

 

50,076

 

 

$19.38

 

 

 

50,076

 

 

 

149,924

 

 

Note J – Revenue Recognition

 

The Company’s revenues result from the sale of goods and services and reflect the consideration to which the Company expects to be entitled. The Company records revenues in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers.”  The Company has defined purchase orders as contracts in accordance with ASC Topic 606. For its customer contracts, the Company identifies its performance obligations, which are delivering goods or services, determines the transaction price, allocates the contract transaction price to the performance obligations (when applicable), and recognizes the revenue when (or as) the performance obligation is transferred to the customer. A good or service is transferred when the customer obtains control of that good or service. The Company’s revenues are recorded at a point in time from the sale of tangible products. Revenues are recognized when products are shipped.

 

Customer volume rebates, product returns, discount and allowance are variable considerations and are recorded as a reduction of revenue in the same period that the related sales are recorded. The Company has reviewed the overall sales transactions for variable consideration and has determined that these costs are not material.

 

The Company has no future performance obligations and does not capitalize costs to obtain or fulfill contracts.

 

 
12

Table of Contents

 

Note K - Income Taxes

 

The Company files income tax returns in the U.S. federal jurisdiction, and in various states and foreign jurisdictions. With limited exceptions, the Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019 and is no longer subject to non-U.S. income tax examinations by foreign tax authorities for years prior to 2017.

 

The total amount of unrecognized tax benefits could increase or decrease within the next 12 months for several reasons, including the closure of federal, state, and foreign tax years by expiration of the statute of limitations and the recognition and measurement considerations under FASB ASC Topic 740, “Income Taxes.”  There have been no significant changes to the value of unrecognized tax benefits during the three months ended March 30, 2024. The Company believes that it is reasonably possible that the total amount of unrecognized tax benefits will not increase or decrease significantly over the next twelve months.

 

Note L - Retirement Benefit Plans

 

The Company has four non-contributory defined benefit pension plans covering most U.S. employees. All of these pension plans are frozen and participants in these plans have not accrued benefits since the date on which these plans were frozen. Plan benefits are generally based upon age at retirement, years of service and, for the plan covering salaried employees, the level of compensation. The Company also sponsors unfunded non-qualified supplemental retirement plans that provide certain former officers with benefits in excess of limits imposed by federal tax law.

 

The Company also provides health care and life insurance for retired salaried employees in the United States who meet specific eligibility requirements.

 

Significant disclosures relating to these benefit plans for the first quarter of fiscal years 2024 and 2023 are as follows:

 

 

 

Pension Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$178,003

 

 

$216,153

 

Interest cost

 

 

966,702

 

 

 

990,054

 

Expected return on plan assets

 

 

(1,099,035)

 

 

(1,049,016)

Amortization of the net loss

 

 

327,365

 

 

 

342,865

 

Net periodic benefit cost

 

$373,035

 

 

$500,056

 

 

 

 

Other Postretirement Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$3,574

 

 

$6,486

 

Interest cost

 

 

12,951

 

 

 

14,533

 

Expected return on plan assets

 

 

(4,684)

 

 

(4,849)

Amortization of prior service cost

 

 

1,060

 

 

 

1,060

 

Amortization of the net loss

 

 

(19,567)

 

 

(16,895)

Net periodic benefit (gain) cost

 

$(6,666)

 

$335

 

 

The Company’s funding policy with respect to its qualified plans is to contribute at least the minimum amount required by applicable laws and regulations. In fiscal year 2024, the Company expects to make cash contributions to its qualified pension plans of approximately $2,100,000 and approximately $50,000 into its other postretirement plan. As of March 30, 2024, the Company has contributed $450,000 to its pension plans and $7,000 to its postretirement plan and expects to make the remaining contributions as required during the remainder of the fiscal year.

 

 
13

Table of Contents

 

The Company has a contributory savings plan under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”) covering substantially all U.S. non-union employees. The 401(k) Plan allows participants to make voluntary contributions from their annual compensation on a pre-tax basis, subject to limitations under the Internal Revenue Code. The 401(k) Plan provides for contributions by the Company at its discretion.

 

The Company made contributions to the 401(k) Plan as follows:

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Regular matching contribution

 

$285,563

 

 

$252,761

 

Transitional credit contribution

 

 

28,906

 

 

 

34,320

 

Non-discretionary contribution

 

 

110,890

 

 

 

431,950

 

Total contributions for the period

 

$425,359

 

 

$719,031

 

 

The non-discretionary contribution of $328,953 made in the three months ended April 1, 2023, was accrued for, and expensed in the prior fiscal year.

 

Effective January 1, 2023, the non-discretionary contributions are being contributed on a weekly basis.

 

Note M - Recent Accounting Pronouncements

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which amends the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We do not expect this new standard to have a significant impact on our disclosures.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit disaggregated between domestic and foreign and (3) income tax expense or benefit from continuing operations disaggregated by federal, state, and foreign. The update also requires entities to disclose their income tax payments to various jurisdictions. This standard is effective for fiscal years beginning after December 15, 2024. We do not expect this new standard to have a significant impact on our disclosures.

 

The Company has implemented all new accounting pronouncements that are in effect and that could impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued, but are not yet effective, that might have a material impact on the consolidated financial statements of the Company.

 

Note N - Concentration of Risk

 

Credit Risk

 

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual obligations to the Company, as and when they become due. The primary credit risk for the Company is its accounts receivable due from customers. The Company has established credit limits for customers and monitors their balances to mitigate the risk of loss. As of March 30, 2024, there was one significant concentration of credit risk with a customer, who had receivables representing 12% of our net accounts receivable. One single customer represented 12% of the Company’s net accounts receivable as of December 30, 2023. The maximum exposure to credit risk is primarily represented by the carrying amount of the Company’s accounts receivable.

 

The Company has deposits that exceed amounts up to $250,000 that are insured by the Federal Deposit Insurance Corporation (FDIC), but the Company does not consider this a significant concentration of credit risk based on the strength of the financial institution.

 

 
14

Table of Contents

 

Interest Rate Risk

 

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s debt, which bears interest at variable rates based on term SOFR, plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, depending on the Company’s senior net leverage ratio.

 

Currency Exchange Rate Risk

 

The Company’s currency exposure is concentrated in the Canadian dollar, Mexican peso, New Taiwan dollar, Chinese RMB, and Hong Kong dollar. Because of the Company’s limited exposure to any single foreign market, any exchange gains or losses have not been material and are not expected to be material in the future. As a result, the Company does not attempt to mitigate its foreign currency exposure through the acquisition of any speculative or leveraged financial instruments.

 

Note O – Business Acquisition

 

On June 29, 2023, the Company acquired certain assets, including accounts receivable, inventories, furniture, fixtures and equipment, intellectual property rights, and rights existing under all sales and purchase agreements, and assumed certain liabilities of Sureflex, Inc. (“Sureflex”). These assets are held in our Velvac, Inc. (“Velvac”) subsidiary. We expect that Sureflex, which manufactures tractor-trailer electrical connection cable assemblies, will enable the Company to manufacture electrical products and become more competitive with respect to cost and quality.

 

The acquisition of Sureflex was accounted for under Business Combinations (ASC Topic 805). The acquired business is included in the consolidated operating results of the Company from the effective date of the acquisition. The excess of the cost of Sureflex over the fair market value of the net assets acquired of $0.5 million has been recorded as goodwill.

 

Neither the actual results nor the pro forma effects of the Sureflex acquisition are material to the Company’s financial statements.

 

 
15

Table of Contents

 

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion is intended to highlight significant changes in the financial position and results of operations of The Eastern Company (together with its consolidated subsidiaries, the “Company,” “we,” “us” or “our”) for the three months ended March 30, 2024. This Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Consolidated Financial Statements and Notes thereto for the fiscal year ended December 30, 2023 and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations, both of which are contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023, which was filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2024 (the “2023 Form 10-K”).

 

The Company’s fiscal year is a 52-53-week fiscal year ending on the Saturday nearest to December 31. References to 2023, the 2023 fiscal year or fiscal 2023 mean the 52-week period ended on December 30, 2023, and references to 2024, the 2024 fiscal year or fiscal 2024 mean the 52-week period ending on December 28, 2024. In a 52-week fiscal year, each quarter has 13 weeks. References to the first quarter of 2023, the first fiscal quarter of 2023, the first quarter of fiscal 2023 or the three months ended April 1, 2023, mean the period from January 1, 2023 to April 1, 2023. References to the first quarter of 2024, the first fiscal quarter of 2024, the first quarter of fiscal 2024, or the three months ended March 30, 2024 mean the 13-week period from December 31, 2023 to March 30, 2024.

 

Safe Harbor for Forward-Looking Statements

 

Statements contained in this Quarterly Report on Form 10-Q of the Company that are not based on historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terminology such as “would,” “should,” “could,” “may,” “will,” “expect,” “believe,” “estimate,” “anticipate,” “intend,” “continue,” “plan,” “potential,” “opportunities,” or similar terms or variations of those terms or the negative of those terms. There are many factors that affect the Company’s business and the results of its operations and that may cause the actual results of operations in future periods to differ materially from those currently expected or anticipated. These factors include:

 

 

·

the impact of higher raw material and component costs and cost inflation, supply chain disruptions and shortages, particularly with respect to steel, plastics, scrap iron, zinc, copper, and electronic components;

 

·

delays in delivery of our products to our customers;

 

·

the impact of global economic conditions and rising interest rates, and more specifically conditions in the automotive, construction, aerospace, energy, oil and gas, transportation, electronic, and general industrial markets, including the impact, length and degree of economic downturns on the customers and markets we serve and demand for our products, reductions in production levels, the availability, terms and cost of financing, including borrowings under credit arrangements or agreements, the potential impact of bank failures on our ability to access financing or capital markets, and the impact of market conditions on pension plan funded status;

 

·

restrictions on operating flexibility imposed by the agreement governing our credit facility;

 

·

risks associated with doing business overseas, including fluctuations in exchange rates and the inability to repatriate foreign cash, the impact on cost structure and on economic conditions as a result of actual and threatened increases in trade tariffs and the impact of political, economic, and social instability;

 

·

the inability to achieve the savings expected from global sourcing of materials;

 

·

lower-cost competition;

 

·

our ability to design, introduce and sell new or updated products and related components;

 

·

market acceptance of our products;

 

·

the inability to attain expected benefits from acquisitions or the inability to effectively integrate acquired businesses and achieve expected synergies;

 

·

costs and liabilities associated with environmental compliance;

 

·

the impact of climate change, natural disasters, geopolitical events, and public health crises, including pandemics (such as COVID-19) and epidemics, and any related Company or government policies or actions;

 

·

military conflict (including the Russia/Ukraine conflict, the conflict in Israel and surrounding areas, the possible expansion of such conflicts and geopolitical consequences) or terrorist threats and the possible responses by the U.S. and foreign governments;

 

·

failure to protect our intellectual property;

 

·

cyberattacks; and

 

·

materially adverse or unanticipated legal judgments, fines, penalties, or settlements.

 

 
16

Table of Contents

 

The Company is also subject to other risks identified and discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Item 1A, Risk Factors, and in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, of the 2023 Form 10-K, and that may be identified from time to time in our quarterly reports on Form 10-Q, current reports on Form 8-K and other filings we make with the SEC.

 

Although the Company believes it has an appropriate business strategy and the resources necessary for its operations, future revenue and margin trends cannot be reliably predicted, and the Company may alter its business strategies to address changing conditions. Also, the Company makes estimates and assumptions that may materially affect reported amounts and disclosures. These relate to valuation allowances for accounts receivable and excess and obsolete inventories, accruals for pensions and other postretirement benefits (including forecasted future cost increases and returns on plan assets), provisions for depreciation (estimating useful lives), uncertain tax positions, and, on occasion, accruals for contingent losses. The Company undertakes no obligation to update, alter, or otherwise revise any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future events, or otherwise, except as required by law.

 

General Overview

 

Net sales in the first quarter of 2024 decreased 6% to $67.9 million from $72.5 million in the corresponding period in 2023. Sales declined in the first quarter of 2024 primarily due to lower demand for truck accessories and returnable transport packaging products, partially offset by increased demand for truck mirror assemblies. Our backlog as of March 30, 2024 increased 35% to $97.4 million from $72.0 million as of April 1, 2023, driven by increased orders for various truck mirror assemblies.

 

Net sales of existing products declined 11% in the first quarter of 2024 compared to the corresponding period in 2023. Price increases and new products increased net sales by 5% in the first quarter of 2024 compared to the corresponding period in 2023. New products included various truck mirror assemblies, rotary latches, D-rings, and mirror cams.

 

Cost of products sold decreased $5.3 million, or 9%, in the first quarter of 2024 compared to the corresponding period in 2023. The decreases in the first quarter of 2024 are primarily due to lower sales volumes. Additionally, the Company paid tariff costs on China-sourced products of approximately $0.7 million in the first quarter of 2024 compared to $0.6 million in the first quarter of fiscal 2023. Most tariffs on China-sourced products have been recovered through price increases.

 

Gross margin as a percentage of sales was 24% in the first quarter of 2024 compared to 21% in the first quarter of fiscal 2023. Our gross margins in the first quarter of 2024 primarily reflect the impact of price increases to customers to recover increases in raw material costs and other cost savings initiatives.

 

Product development expenses were flat in the first quarter of 2024 compared to the corresponding period in 2023 as we continue to invest in new products at Eberhard, Velvac and Big 3. As a percentage of net sales, product development costs were 2.0% for the first quarter of 2024 compared to 1.9% for the corresponding period in 2023.

 

Selling, general and administrative expenses decreased $0.4 million, or 4%, in the first quarter of 2024 when compared to the first quarter of 2023 primarily due to lower legal, professional, and selling costs and payroll-related expenses. In the first quarter of 2023, selling, general and administrative expenses included severance and other accrued compensation expenses of $1.8 million related to the elimination of the chief operating officer position and the departure of our previous chief executive officer.

 

Interest expense increased $0.1 million in the first quarter of 2024 compared to the corresponding period in 2023 due to higher interest rates.

 

Other income and expense of $0.0 million increased $0.6 million in the first quarter of 2024 when compared to the corresponding period in 2023. The increase in other income of $0.6 million in the first quarter of 2024 was primarily driven by an unfavorable final working capital adjustment of $0.4 million related to the sale of the Greenwald business in the first quarter of 2023.

 

Net income for the first quarter of fiscal 2024 was $1.9 million, or $0.31 per diluted share compared to net income of $0.6 million, or $0.10 per diluted share, for the comparable period in 2023.

 

A more detailed analysis of the Company’s results of operations and financial condition follows.

 

 
17

Table of Contents

 

Results of Operations

 

The following table shows, for the periods indicated, selected line items from the condensed consolidated statements of operations as a percentage of net sales:

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

 

 

 

 

 

 

 

Net sales

 

 

100.0%

 

 

100.0%

Cost of products sold

 

 

76.2%

 

 

78.6%

Gross margin

 

 

23.8%

 

 

21.4%

Product development expense

 

 

2.0%

 

 

1.9%

Selling and administrative expense

 

 

16.9%

 

 

16.5%

Operating Profit

 

 

4.9%

 

 

3.0%

 

The following table shows the change in sales and operating profit for the first quarter of 2024 compared to the first quarter of 2023 (dollars in thousands):

 

 

 

Three Months

 

 

 

Ended

 

 

 

March 30, 2024

 

 

 

 

 

Net Sales

 

$(4,566)

 

 

 

 

 

Volume

 

 

-11.0%

Price

 

 

2.0%

New products

 

 

2.7%

 

 

 

-6.3%

 

 

 

 

 

Operating Profit

 

$1,178

 

 

Liquidity and Sources of Capital

 

The Company generated $3.6 million of cash from operations during the first three months of fiscal 2024 compared to generating $6.9 million during the first three months of fiscal 2023. Cash flow from operations in the first three months of 2024 was lower when compared to the corresponding period in 2023 primarily due to increases in accounts receivable and lower reductions in inventory, partially offset by increases in accounts payable.

 

Additions to property, plant, and equipment were $1.8 million and $1.2 million for the first three months of 2024 and 2023, respectively. As of March 30, 2024, there was approximately $3.0 million of outstanding commitments for capital expenditures.

 

 
18

Table of Contents

 

The following table shows key financial ratios at the end of each specified period:

 

 

 

First

Quarter

2024

 

 

First

Quarter

2023

 

 

Fiscal

Year

2023

 

Current ratio

 

 

2.6

 

 

 

2.7

 

 

 

2.6

 

Average days’ sales in accounts receivable

 

 

58

 

 

 

57

 

 

 

48

 

Inventory turnover

 

 

3.5

 

 

 

4.0

 

 

 

3.5

 

Total debt to shareholders’ equity

 

 

32.1%

 

 

46.6%

 

 

33.2%

 

The following table shows important liquidity measures as of the balance sheet date for each specified period or for the period, as applicable (in millions):

 

 

 

First

 

 

First

 

 

Fiscal

 

 

 

Quarter

 

 

Quarter

 

 

Year

 

 

 

2024

 

 

2023

 

 

2023

 

Cash and cash equivalents

 

 

 

 

 

 

 

 

 

- Held in the United States

 

$6.0

 

 

$9.7

 

 

$7.0

 

- Held by a foreign subsidiary

 

 

1.4

 

 

 

3.4

 

 

 

1.3

 

 

 

 

7.4

 

 

 

13.1

 

 

 

8.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Working capital

 

 

71.3

 

 

 

76.7

 

 

 

69.5

 

Net cash provided by operating activities

 

 

3.6

 

 

 

6.9

 

 

 

26.5

 

Change in working capital impact on net cash used in operating activities

 

 

(1.2)

 

 

3.6

 

 

 

9.7

 

Net cash (used in) provided by investing activities

 

 

(2.8)

 

 

1.1

 

 

 

(5.4)

Net cash used in financing activities

 

 

(1.7)

 

 

(5.1)

 

 

(22.9)

 

Inventories of $55.8 million as of March 30, 2024 declined by $3.4 million, or 5.8%, when compared to $59.3 million at the end of fiscal year 2023 and declined $1.8 million, or 3.1%, when compared to $57.7 million at the end of the first quarter of fiscal 2023. Accounts receivable, less allowances, were $42.9 million as of March 30, 2024, as compared to $37.1 million at 2023 fiscal year end and $44.5 million at the end of the first quarter of fiscal 2023.

 

On June 16, 2023, the Company entered into a credit agreement with TD Bank, N.A., Wells Fargo Bank, Bank of America, and M&T Bank as lenders (the “Credit Agreement”), and incurred indebtedness under the Credit Agreement in the aggregate principal amount of $60 million in the form of a term loan, the proceeds of which were used to repay the Company’s remaining outstanding term loan and to terminate its existing credit facility with Santander Bank.  See Note G for additional information regarding the terms of the Credit Agreement, including repayment terms, interest rates and applicable loan covenants. Under the terms of the Credit Agreement, the Company is subject to restrictive covenants that limit our ability to, among other things, incur additional indebtedness, pay dividends, or make other distributions, and consolidate, merge, sell or otherwise dispose of assets, as well as financial covenants that require us to maintain a fixed charge coverage ratio and a maximum senior net leverage ratio.  These covenants may limit how we conduct our business, and in the event of certain defaults, our repayment obligations may be accelerated. We were in compliance with all our covenants as of March 30, 2024 and had no outstanding borrowings under the revolving commitment portion of the credit facility as of this date.

 

Cash, cash flow from operating activities and funds available under the revolving credit portion of the Credit Agreement are expected to be sufficient to cover future foreseeable working capital requirements in the short-term (i.e., the next 12 months from March 30, 2024) and separately in the long-term (i.e., beyond the next 12 months). However, the Company cannot provide any assurances of the availability of future financing or the terms on which it might be available. In addition, the interest rate on borrowings under the Credit Agreement varies based on our senior net leverage ratio, and the Credit Agreement requires us to maintain a senior net leverage ratio not to exceed 3.50 to 1 and a fixed charge coverage ratio to be not less than 1.25 to 1. A decrease in earnings due to the impact of current economic conditions and inflationary pressures or the resulting harm to the financial condition of our customers, or an increase in indebtedness incurred to offset such a decrease in earnings, would have a negative impact on our senior net leverage ratio and our fixed charge coverage ratio, which in turn would increase the cost of borrowing under the Credit Agreement and could cause us to fail to comply with the covenants under our Credit Agreement.

 

 
19

Table of Contents

 

In addition to funding capital requirements, we may use available cash to pay down our indebtedness, to make investments, which may include investments in publicly traded securities, or to make acquisitions that we believe will complement or expand our existing businesses.

 

As of the end of the first quarter of 2024, the Company does not have any off-balance sheet arrangements that have or are reasonably likely to have a material current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Critical Accounting Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires management to make judgments, estimates and assumptions regarding uncertainties that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. For a full description of our critical accounting estimates, refer to Management’s Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 of the 2023 Form 10-K. While there have been no material changes to our critical accounting estimates, we continue to monitor the methodologies and assumptions underlying such critical accounting estimates.

 

 
20

Table of Contents

 

Non-GAAP Financial Measures

 

The non-GAAP financial measures we provide in this report should be viewed in addition to, and not as an alternative for, results prepared in accordance with U.S. GAAP.

 

To supplement the consolidated financial statements prepared in accordance with U.S. GAAP, we have presented Adjusted Net Income, Adjusted Earnings Per Share and Adjusted EBITDA, which are considered non-GAAP financial measures. The non-GAAP financial measures presented may differ from similarly titled non-GAAP financial measures presented by other companies, and other companies may not define these non-GAAP financial measures in the same way. These measures are not substitutes for their comparable U.S. GAAP financial measures, such as net sales, net income, diluted earnings per share, or other measures prescribed by U.S. GAAP, and there are limitations to using non-GAAP financial measures.

 

Adjusted Net Income is defined as net income excluding, when incurred, gains or losses that we do not believe reflect our ongoing operations, including, for example, the impacts of impairment losses, gains/losses on the sale of subsidiaries, property and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses, executive severance, and restructuring costs.  Adjusted Net Income is a tool that can assist management and investors in comparing our performance on a consistent basis across periods by removing the impact of certain items that management believes do not directly reflect our underlying operating performance.

 

Adjusted Earnings Per Share is defined as earnings per share excluding, when incurred, certain per share gains or losses that we do not believe reflect our ongoing operations, including, for example, the impacts of impairment losses, gains/losses on the sale of subsidiaries, property and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses, executive severance, and restructuring costs.  We believe that Adjusted Earnings Per Share provides important comparability of underlying operational results, allowing investors and management to access operating performance on a consistent basis from period to period.

 

Adjusted EBITDA is defined as net income before interest expense, provision for income taxes, and depreciation and amortization and excluding, when incurred, the impacts of certain losses or gains that we do not believe reflect our ongoing operations, including, for example, impairment losses, gains/losses on sale of subsidiaries, property and facilities, transaction expenses primarily relating to acquisitions and divestitures, factory start-up costs, factory relocation expenses, executive severance, and restructuring expenses.  Adjusted EBITDA is a tool that can assist management and investors in comparing our performance on a consistent basis by removing the impact of certain items that management believes do not directly reflect our underlying operations.

 

Management uses such measures to evaluate performance period over period, to analyze the underlying trends in our business, to assess our performance relative to our competitors, and to establish operational goals and forecasts that are used in allocating resources. These financial measures should not be considered in isolation from, or as a replacement for, U.S. GAAP financial measures.

 

We believe that presenting non-GAAP financial measures in addition to U.S. GAAP financial measures provides investors greater transparency to the information used by our management for its financial and operational decision-making. We further believe that providing this information better enables our investors to understand our operating performance and to evaluate the methodology used by management to evaluate and measure such performance.

 

 
21

Table of Contents

 

Reconciliation of Non-GAAP Measures

 

 

 

 

 

 

Adjusted Net Income and Adjusted Earnings per Share Calculation

 

For the Three Months ended March 30, 2024 and April 1, 2023

 

 

 

 

 

 

($000's)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Net income as reported per generally accepted accounting principles (GAAP)

 

$1,948

 

 

$607

 

 

 

 

 

 

 

 

 

 

Earnings per share as reported under generally accepted accounting principles (GAAP):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.31

 

 

$0.10

 

Diluted

 

$0.31

 

 

$0.10

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

Severance and accrued compensation

 

 

-

 

 

 

1,799a

Greenwald final sale adjustment

 

 

-

 

 

 

390b

Non-GAAP tax impact of adjustments (1)

 

 

-

 

 

 

(547)

Total adjustments (non-GAAP)

 

$-

 

 

$1,642

 

 

 

 

 

 

 

 

 

 

Adjusted net income

 

$1,948

 

 

$2,249

 

 

 

 

 

 

 

 

 

 

Adjusted earnings per share (non-GAAP):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$0.31

 

 

$0.36

 

Diluted

 

$0.31

 

 

$0.36

 

      

(1) We estimate the tax effect of the items identified to determine a non-GAAP annual effective tax rate applied to the pre-tax amount in order to calculate the non-GAAP provision for income taxes 

     

a) Severance expenses associated with accrued compensation and severance related to the elimination of the Chief Operating Officer position and the departure of the Chief Executive Officer 

     

b) Final settlement of working capital adjustment associated with Greenwald sale    

 

 
22

Table of Contents

 

Reconciliation of Non-GAAP Measures

 

 

 

 

Adjusted EBITDA Calculation

 

 

 

 

For the Three Months ended March 30, 2024 and April 1, 2023

 

 

 

 

($000's)

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

 

 

 

 

 

 

 

Net income as reported per generally accepted accounting principles (GAAP)

 

$1,948

 

 

$607

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

845

 

 

 

726

 

Provision for income taxes

 

 

555

 

 

 

195

 

Depreciation and amortization

 

 

1,876

 

 

 

1,815

 

Severance and accrued compensation

 

 

-

 

 

 

1,799a

Greenwald final sale adjustment

 

 

-

 

 

 

390b

Adjusted EBITDA

 

$5,224

 

 

$5,532

 

 

a) Severance expenses associated with accrued compensation and severance related to the elimination of the Chief Operating Officer position and the departure of the Chief Executive Officer

 

b) Final settlement of working capital adjustment associated with Greenwald sale

 

 
23

Table of Contents

 

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a result of the Company’s status as a smaller reporting company pursuant to Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company is not required to provide information under this Item 3.

 

ITEM 4 – CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures:

 

As of March 30, 2024, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Chief Executive Officer (the “CEO”) and the Chief Financial Officer (the “CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) pursuant to Exchange Act Rule 13a-15.  As defined in Exchange Act Rules 13a-15(e) and 15d-15(e), “the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.  Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.”

 

The Company believes that a controls system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. The Company’s disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives, and the CEO and CFO have concluded that these controls and procedures are effective at the “reasonable assurance” level as of March 30, 2024.

 

Changes in Internal Control Over Financial Reporting:

 

During the period covered by this Quarterly Report on Form 10-Q, there were no changes in the Company's internal control over financial reporting that have materially affected or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 
24

Table of Contents

 

PART II – OTHER INFORMATION

 

ITEM 1 – LEGAL PROCEEDINGS

 

The Company is a party to various legal proceedings from time to time related to its normal business operations. As of the end of the quarter ended March 30, 2024, the Company does not have any material pending legal proceedings, other than as set forth in Part I, Item 3, Legal Proceedings, of the 2023 Form 10-K, or any material legal proceedings known to be contemplated by governmental authorities.

 

ITEM 1A – RISK FACTORS

 

The Company’s business is subject to several risks, some of which are beyond its control. In addition to the other information set forth in this Quarterly Report on Form 10-Q, the Company’s shareholders should carefully consider the risk factors discussed in Part I, Item 1A, Risk Factors of the 2023 Form 10-K. These risk factors could have a material adverse effect on the Company’s business, results of operations, financial condition and/or liquidity and could cause our operating results to vary significantly from period to period. As of March 30, 2024, there have been no material changes to the risk factors disclosed in the 2023 Form 10-K. The Company may disclose changes to such risk factors or disclose additional risk factors from time to time in its future filings with the SEC. Additional risks and uncertainties not currently known to the Company or that it currently deems to be immaterial also may materially adversely affect its business, financial condition, or operating results.

 

ITEM 2 – UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On May 2, 2023, the Company’s existing share purchase program expired, under which the Company repurchased a total of 139,716 shares of Company common stock. On August 21, 2023, the Company announced that the Board of Directors of the Company had approved a new share repurchase program authorizing the Company to repurchase up to 200,000 shares of the Company’s common stock through August 20, 2028. The Company’s new share repurchase program does not obligate it to acquire the Company’s common stock at any specific cost per share. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Exchange Act. Below is a summary of the Company’s share repurchases during the first quarter of 2024 under the new share repurchase program.

Period

 

Total

Number of

Shares

Purchased

 

 

Average

Price Paid

Per Share

 

 

Total Number

of Shares

Purchased as

Part of Publicly Announced

Plans or

Programs

 

 

Maximum

Number of

Shares that

may yet be Purchased

Under the

Plans or

Programs

 

December 31, 2023 - February 3, 2024

 

 

7,174

 

 

$22.99

 

 

 

7,174

 

 

 

152,826

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

February 4, 2024 - March 2, 2024

 

 

2,072

 

 

 

24.10

 

 

 

2,072

 

 

 

150,754

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 3, 2024 - March 30, 2024

 

 

830

 

 

 

24.01

 

 

 

830

 

 

 

149,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

10,076

 

 

$23.30

 

 

 

10,076

 

 

 

149,924

 

 

ITEM 3 – DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4 – MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5 – OTHER INFORMATION

 

(a) None.

 

(b) None.

 

(c) During the fourth quarter of 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1trading arrangement” or “non-Rule 10b5-1trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 
25

Table of Contents

 

ITEM 6 – EXHIBITS

 

3.1)

 

Restated Certificate of Incorporation of the Company, as amended (conformed copy) (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q filed on May 6, 2020).

 

 

 

3.2)

 

Amended and Restated By-Laws of the Company, as amended through March 11, 2022 (incorporated by reference to Exhibit 3(ii) to the Company’s Current Report on Form 8-K filed on March 11, 2022).

 

 

 

31)

 

Certifications required by Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

 

 

 

32)

 

Certifications pursuant to Rule 13a-14(b) and 18 USC 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**

 

 

 

101)

 

The following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 30, 2024, formatted in Inline XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Income (Unaudited) for the three months ended March 30, 2024 and April 1, 2023; (ii) Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three months ended March 30, 2024, and April 1, 2023; (iii) Condensed Consolidated Balance Sheets (Unaudited) as of March 30, 2024 and December 30, 2023; (iv) Condensed Consolidated Statements of Cash Flows (Unaudited) for the three months ended March 30, 2024 and April 1, 2023; and (iv) Notes to the Condensed Consolidated Financial Statements (Unaudited).**

 

 

 

104)

 

Cover Page Interactive Data File (formatted as Inline XBRL and included in Exhibit 101). **

 

* Filed herewith.

** Furnished herewith

 

 
26

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

THE EASTERN COMPANY

 

 

(Registrant)

 

 

DATE:  May 6, 2024

/s/Mark Hernandez

 

 

Mark Hernandez

President and Chief Executive Officer

 

 

 

 

DATE:  May 6, 2024

/s/Nicholas Vlahos

 

 

Nicholas Vlahos

Vice President and Chief Financial Officer

 

 

 
27

 

nullnullv3.24.1.u1
Cover
3 Months Ended
Mar. 30, 2024
shares
Cover [Abstract]  
Entity Registrant Name THE EASTERN COMPANY
Entity Central Index Key 0000031107
Document Type 10-Q
Amendment Flag false
Current Fiscal Year End Date --12-30
Entity Small Business true
Entity Shell Company false
Entity Emerging Growth Company false
Entity Current Reporting Status Yes
Document Period End Date Mar. 30, 2024
Entity Filer Category Accelerated Filer
Document Fiscal Period Focus Q1
Document Fiscal Year Focus 2024
Entity Common Stock Shares Outstanding 6,233,510
Entity File Number 001-35383
Entity Incorporation State Country Code CT
Entity Tax Identification Number 06-0330020
Entity Address Address Line 1 3 Enterprise Drive
Entity Address Address Line 2 Suite 408
Entity Address City Or Town Shelton
Entity Address State Or Province CT
Entity Address Postal Zip Code 06484
City Area Code 203
Local Phone Number 729-2255
Security 12b Title Common Stock, No Par Value
Trading Symbol EML
Security Exchange Name NASDAQ
Document Quarterly Report true
Document Transition Report false
Entity Interactive Data Current Yes
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited)    
Net sales $ 67,929,087 $ 72,495,367
Cost of products sold (51,732,988) (56,997,668)
Gross margin 16,196,099 15,497,699
Product development expense (1,359,797) (1,401,199)
Selling and administrative expenses (11,498,958) (11,937,637)
Operating profit 3,337,344 2,158,863
Interest expense (845,035) (726,006)
Other income (expense) 10,354 (630,699)
Income before income taxes 2,502,663 802,158
Income tax expense (555,091) (194,845)
Net income $ 1,947,572 $ 607,313
Earnings per share:    
Basic $ 0.31 $ 0.10
Diluted 0.31 0.10
Cash dividends per share: $ 0.11 $ 0.11
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)    
Net income $ 1,947,572 $ 607,313
Other comprehensive (loss) income:    
Change in foreign currency translation (157,000) 336,585
Change in fair value of foreign currency swap, net of tax cost (benefit) of: 2024 - $96,724; 2023 - $(87,691) 403,016 (277,687)
Change in pension and postretirement benefit costs, net of taxes of: 2024 - $71,355; 2023 - $74,360 243,336 252,668
Total other comprehensive income (loss) 489,352 311,566
Comprehensive income $ 2,436,924 $ 918,879
v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Mar. 30, 2024
Dec. 30, 2023
Current Assets    
Cash and cash equivalents $ 7,356,444 $ 8,299,453
Marketable Securities 2,127,735 986,477
Accounts receivable, less allowances: 2024 - $541,103; 2023 - $564,816 42,881,758 37,057,488
Inventories 55,847,071 59,272,207
Current portion of notes receivable 618,231 573,269
Prepaid expenses and other assets 6,199,897 6,047,814
Total Current Assets 115,031,136 112,236,708
Property, Plant and Equipment 61,842,148 60,270,096
Accumulated depreciation (32,710,475) (31,980,335)
Property, Plant and Equipment, Net 29,131,673 28,289,761
Goodwill 70,722,962 70,776,893
Trademarks 5,514,884 5,514,960
Patents and other intangibles net of accumulated amortization 14,360,192 15,325,927
Long term notes receivable, less current portion 329,970 374,932
Deferred Income Taxes 2,283,571 2,283,571
Right of Use Assets 16,521,127 17,236,449
Total Other Assets 109,732,706 111,512,732
TOTAL ASSETS 253,895,515 252,039,201
Current Liabilities    
Accounts payable 26,971,547 25,319,473
Accrued compensation 4,636,088 5,379,381
Other accrued expenses 4,874,024 4,556,623
Current portion of operating lease liability 4,195,865 4,424,369
Current portion of finance lease liability 182,290 182,010
Current portion of long-term debt 2,871,870 2,871,870
Total Current Liabilities 43,731,684 42,733,726
Other long-term liabilities 640,724 640,724
Operating lease liability, less current portion 12,325,261 12,812,079
Finance lease liability, less current portion 696,584 728,100
Long-term debt, less current portion 40,271,398 41,063,865
Accrued postretirement benefits 565,727 554,758
Accrued pension cost 21,150,758 21,025,365
Total Liabilities 119,382,136 119,558,617
Shareholders' Equity    
Common Stock, no par value, Authorized: 50,000,000 shares Issued: 9,118,031 shares as of 2024 and 9,091,815 shares as of 2023 Outstanding: 6,233,510 shares as of 2024 and 6,217,370 shares as of 2023 34,464,595 33,950,859
Treasury Stock: 2,884,521 shares as of 2024 and 2,874,445 shares as of 2023 (23,515,267) (23,280,467)
Retained earnings 146,069,675 144,805,168
Accumulated other comprehensive loss:    
Foreign currency translation (1,023,599) (866,599)
Unrealized gain on foreign currency swap, net of tax 403,016 0
Unrecognized net pension and postretirement benefit costs, net of tax (21,885,041) (22,128,377)
Accumulated other comprehensive loss (22,505,624) (22,994,976)
Total Shareholders' Equity 134,513,379 132,480,584
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $ 253,895,515 $ 252,039,201
v3.24.1.u1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Mar. 30, 2024
Dec. 30, 2023
CONDENSED CONSOLIDATED BALANCE SHEETS    
Accounts receivable, allowance for doubtful accounts $ 541,103 $ 564,816
Shareholders' Equity    
Voting Preferred Stock, par value (in dollars per share) $ 0 $ 0
Voting Preferred Stock, shares authorized (in shares) 1,000,000 1,000,000
Nonvoting Preferred Stock, par value (in dollars per share) $ 0 $ 0
Nonvoting Preferred Stock, shares authorized (in shares) 1,000,000 1,000,000
Common Stock, par value (in dollars per share) $ 0 $ 0
Common Stock, shares authorized (in shares) 50,000,000 50,000,000
Common Stock, shares issued (in shares) 9,118,031 9,091,815
Common Stock, shares outstanding (in shares) 6,233,510 6,217,370
Treasury Stock, shares (in shares) 2,884,521 2,874,445
v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Operating Activities    
Net income $ 1,947,572 $ 607,313
Depreciation and amortization 1,876,124 1,814,749
Reduction in carrying amount of ROU assets 715,322 631,368
Unrecognized pension and postretirement benefits 445,218 880,421
Loss on sale of equipment and other assets 37,330 0
Provision for doubtful accounts (23,000) 3,269
Stock compensation expense (benefit) 513,737 (49,246)
Changes in operating assets and liabilities:    
Accounts receivable (5,898,945) (1,585,976)
Inventories 3,415,931 7,212,179
Prepaid expenses and other (109,507) (37,330)
Other assets 21,710 (155,055)
Accounts payable 3,601,059 (1,031,704)
Accrued compensation (1,000,332) (1,104,186)
Change in operating lease liability (715,322) (639,987)
Other accrued expenses (1,248,705) 314,443
Net cash provided by operating activities 3,578,192 6,860,258
Investing Activities    
Marketable securities (999,960) 0
Payments received from notes receivable 0 2,233,192
Proceeds from sale of equipment 18,000 0
Purchases of property, plant, and equipment (1,776,954) (1,151,205)
Net cash (used in) provided by investing activities (2,758,914) 1,081,987
Financing Activities    
Payments on short term borrowings (revolver) 0 (268,249)
Principal payments on long-term debt (792,467) (4,858,000)
Financing leases, net (31,236) 723,254
Purchase common stock for treasury (234,800) 0
Dividends paid (683,065) (684,293)
Net cash used in financing activities (1,741,568) (5,087,288)
Effect of exchange rate changes on cash (20,719) 28,538
Net change in cash and cash equivalents (943,009) 2,883,495
Cash and cash equivalents at beginning of period 8,299,453  
Cash and cash equivalents at end of period 7,356,444 13,071,017
Supplemental disclosure of cash flow information:    
Interest 831,462 716,763
Income taxes 230,523 (59,681)
Non-cash investing and financing activities    
Right of use asset 140,939 (652,914)
Lease liability $ (140,939) $ (328,721)
v3.24.1.u1
Basis of Presentation
3 Months Ended
Mar. 30, 2024
Basis of Presentation  
Basis of Presentation

Note A – Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X and do not include all the information and footnotes required by generally accepted accounting principles in the United States (“GAAP”) for complete financial statements. Refer to the consolidated financial statements of The Eastern Company (together with its consolidated subsidiaries, the “Company,” “we,” “us” or “our”) and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2023, filed with the Securities and Exchange Commission on March 12, 2024 (the “2023 Form 10-K”), for additional information.

 

The accompanying condensed consolidated financial statements are unaudited. However, in the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary for a fair presentation of the results of operations for interim periods have been reflected therein. Operating results for interim periods are not necessarily indicative of the results that may be expected for the full year. All intercompany accounts and transactions are eliminated.

 

The condensed consolidated balance sheet as of December 30, 2023 has been derived from the audited consolidated balance sheet at that date.

 

The Company’s fiscal year is a 52-53-week fiscal year ending on the Saturday nearest to December 31. References to 2023, the 2023 fiscal year or fiscal 2023 mean the 52-week period ended on December 30, 2023, and references to 2024, the 2024 fiscal year or fiscal 2024 mean the 52-week period ending on December 28, 2024. In a 52-week fiscal year, each quarter has 13 weeks. References to the first quarter of 2023, the first fiscal quarter of 2023, the first quarter of fiscal 2023 or the three months ended April 1, 2023, mean the period from January 1, 2023 to April 1, 2023. References to the first quarter of 2024, the first fiscal quarter of 2024, the first fiscal quarter of 2024 or the three months ended March 30, 2024, mean the 13-week period from December 31, 2023 to March 30, 2024.

 

Certain amounts in the 2023 financial statements have been reclassified to conform with the 2024 presentation with no impact or change to previously reported net income or shareholders’ equity.

v3.24.1.u1
Earnings per Share
3 Months Ended
Mar. 30, 2024
Earnings per share:  
Earnings per Share

Note B – Earnings Per Share

 

The denominators used to calculate earnings per share are as follows:

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Basic:

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

Dilutive stock appreciation rights

 

 

39,727

 

 

 

10,962

 

Denominator for diluted earnings per share

 

 

6,255,400

 

 

 

6,233,989

 

v3.24.1.u1
Fair Value of Instruments
3 Months Ended
Mar. 30, 2024
Fair Value of Instruments  
Fair Value of Instruments

Note C – Fair Value of Instruments

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The company utilizes a fair value hierarchy, which maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value. The fair value hierarchy has three levels of inputs that may be used to measure fair value:

 

Level 1

Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities.

 

 

Level 2

Quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.

 

 

Level 3

Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable.

 

The Company’s financial instruments are primarily investments in marketable securities (Level 1) and pension assets, see Note L, Retirement Benefit Plans.

 

The carrying amounts of other financial instruments (cash and cash equivalents, marketable securities, accounts receivable, accounts payable and debt) as of March 30, 2024 and December 30, 2023, approximate fair value because of their short-term nature and market-based interest rates.

v3.24.1.u1
Inventories
3 Months Ended
Mar. 30, 2024
Inventories  
Inventories

Note D – Inventories

 

Inventories consist of the following components:

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

 

 

 

 

 

Raw material and component parts

 

$23,084,312

 

 

$24,500,087

 

Work in process

 

 

9,381,683

 

 

 

9,957,068

 

Finished goods

 

 

23,381,076

 

 

 

24,815,052

 

Total inventories

 

$55,847,071

 

 

$59,272,207

 

v3.24.1.u1
Goodwill
3 Months Ended
Mar. 30, 2024
Goodwill  
Goodwill

Note E - Goodwill

 

The aggregate carrying amount of goodwill is approximately $70.7 million as of March 30, 2024. No impairment was recognized in the first quarter of 2024.

 

The Company evaluates its reporting units for impairment annually in December, or more frequently if events or circumstances indicate it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Such events and circumstances could include, among other things, increased competition or unexpected loss of market share, significant adverse changes in the markets in which the Company operates, or unexpected business disruptions. The Company tests reporting units for impairment by comparing the estimated fair value of each reporting unit with its carrying amount. If the carrying amount of a reporting unit exceeds its estimated fair value, the Company records an impairment loss based on the difference between fair value and carrying amount not to exceed the associated carrying amount of goodwill. Determining the fair value of a reporting unit involves the use of significant estimates and assumptions. The values assigned to the key assumptions represent management’s assessment of future trends in the relevant industry and have been based on historical data from both external and internal sources.

v3.24.1.u1
Leases
3 Months Ended
Mar. 30, 2024
Leases  
Leases

Note F – Leases

 

The Company presents right-of-use (ROU) assets and lease liabilities on the balance sheet for all leases with terms longer than 12 months, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2016-02, Leases. The Company accounts for non-lease components as part of the lease component to which they relate. Lease accounting involves significant judgements, including making estimates related to the lease term, lease payments, and discount rate.

 

The Company has operating leases for buildings, warehouses, and office equipment. The Company determines whether an arrangement is, or contains, a lease at contract inception. An arrangement contains a lease if the Company has the right to direct the use of and obtain substantially all the economic benefits of an identified asset. ROU assets and lease liabilities are recognized at lease commencement based on the present value of lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. Most leases include one or more options to renew. The exercise of lease renewal options is at our sole discretion. All options to extend, when it is reasonably certain the option will be exercised, have been included in the calculation of the ROU asset and lease liability.

Currently, the Company has twenty-two operating leases with a lease liability of $16.5 million and two finance leases with a lease liability of $0.9 million as of March 30, 2024. The terms and conditions of the leases are determined by the individual agreements. The leases do not contain residual value guarantees, restrictions, or covenants that could cause the Company to incur additional financial obligations. There are no related party lease transactions. There are no leases that have not yet commenced that could create significant rights and obligations for the Company.

 

The future payments (in millions) due under non-cancelable operating and finance leases as of March 30, 2024 are as follows:

 

 

 

Operating

 

 

Finance

 

2024

 

$3.2

 

 

$0.1

 

2025

 

 

3.2

 

 

 

0.2

 

2026

 

 

2.5

 

 

 

0.2

 

2027 and thereafter

 

 

10.2

 

 

 

0.6

 

 

 

 

19.1

 

 

 

1.1

 

Less effects of discounting

 

 

(2.6)

 

 

(0.2)

Lease liabilities recognized

 

$16.5

 

 

$0.9

 

 

As of March 30, 2024, the weighted average lease term for all operating and finance leases is 7.0 and 5.8 years, respectively. The weighted average discount rate associated with operating and finance leases was 6.3% and 6.4%, respectively.

v3.24.1.u1
Debt
3 Months Ended
Mar. 30, 2024
Debt  
Debt

Note G - Debt

 

On June 16, 2023, the Company entered into a credit agreement with TD Bank, N.A., Wells Fargo Bank, Bank of America, and M&T Bank as lenders (the “Credit Agreement”), that included a $60 million term portion and a $30 million revolving commitment portion. The proceeds of the term loan were used to repay the Company’s remaining outstanding term loan and to terminate its existing credit facility with Santander Bank, N.A. (approximately $59 million). The term loan portion of the credit facility requires quarterly principal payments of (i) $750,000 beginning on September 30, 2023 through June 30, 2025, (ii) $1,125,000 beginning on September 30, 2025 through June 30, 2027, and (iii) $1,500,000 beginning on September 30, 2027 through March 31, 2028, with the balance of the term loan payable on the maturity date of June 16, 2028. Amounts outstanding under the revolving portion of the credit facility are generally due and payable on the expiration date of the Credit Agreement (June 16, 2028). The Company can elect to prepay some or all the outstanding balance from time to time without penalty. A commitment fee is payable on the unused portion of the revolving credit facility based on the Company’s consolidated ratio of net debt to adjusted EBITDA from time to time. Currently, the commitment fee is 0.30%. The Company has no borrowings outstanding under the revolving commitment portion of the credit facility as of March 30, 2024.

 

The term loan bears interest at a variable rate based on the term secured overnight financing rate (“SOFR”), plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, depending on the Company’s senior net leverage ratio. Borrowings under the revolving portion bear interest at a variable rate based on, at the Company’s election, a base rate plus an applicable margin of 0.875% to 1.625% or term SOFR, plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, with such margins determined based on the Company’s senior net leverage ratio. The Company’s obligations under the Credit Agreement are secured by a lien on certain of the Company’s and its subsidiaries’ assets pursuant to a Pledge and Security Agreement, dated as of June 16, 2023, with TD Bank N.A., as administrative agent.

 

The Company’s loan covenants under the Credit Agreement require the Company to maintain a senior net leverage ratio not to exceed 3.5 to 1. In addition, the Company is required to maintain a fixed charge coverage ratio to be not less than 1.25 to 1. The Company was in compliance with all its covenants under the Credit Agreement on March 30, 2024, and through the date of filing this Form 10-Q.

v3.24.1.u1
Stock Options and awards
3 Months Ended
Mar. 30, 2024
Stock Options and awards  
Stock Options and awards

Note H - Stock Options and Awards

 

On February 19, 2020, the Board of Directors of the Company (the “Board”) adopted the Eastern Company 2020 Stock Incentive Plan (the “2020 Plan”), which replaced The Eastern Company 2010 Executive Stock Incentive Plan after its expiration in February 2020. On April 29, 2020, at the Company’s 2020 Annual Meeting of Shareholders, the shareholders of the Company approved and adopted the 2020 Plan. The Company has no other existing plan pursuant to which equity awards may be granted.

 

Incentive stock options granted under the 2020 Plan must have exercise prices that are not less than 100% of the fair market value of the Company’s common stock on the dates the stock options are granted. Restricted stock awards may also be granted to participants under the 2020 Plan with restrictions determined by the Compensation Committee of the Board. Under the 2020 Plan, non-qualified stock options granted to participants will have exercise prices determined by the Compensation Committee of the Board.  The Company did not grant any stock awards during the first three months of fiscal 2024 and fiscal 2023. For the first three months of fiscal years 2024 and 2023, the Company used fair market value to determine the associated expense with stock awards.

 

The 2020 Plan also permits the issuance of Stock Appreciation Rights (“SARs”). The SARs are in the form of an option with a cashless exercise price equal to the difference between the fair value of the Company’s common stock at the date of grant and the fair value as of the exercise date resulting in the issuance of the Company’s common stock. The Company did not issue any SARs during the first three months of fiscal 2024 and 2023.

 

Stock-based compensation expense (income), including forfeitures, in connection with SARs and stock awards previously granted to employees was approximately $434,000 and $(184,000) in the first quarter of 2024 and the first quarter of 2023, respectively.

 

As of March 30, 2024, there were 879,924 shares of Company common stock reserved and available for future grant under the 2020 Plan.

 

The following tables set forth the outstanding SARs for the period specified:

 

 

 

Three Months Ended

 

 

Year Ended

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

Outstanding at beginning of period

 

 

13,000

 

 

$24.19

 

 

 

146,166

 

 

$23.22

 

Expired

 

 

(9,000)

 

 

26.30

 

 

 

(50,833)

 

 

24.24

 

Exercised

 

 

-

 

 

 

-

 

 

 

(33,333)

 

 

21.10

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(49,000)

 

 

22.80

 

Outstanding at end of period

 

 

4,000

 

 

$

20.20

 

 

 

13,000

 

 

$

24.19

 

 

SARs Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

 

 

Range of Exercise Prices

 

 

Outstanding as

of March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted

Average

Exercise

Price

 

 

Exercisable

as of

March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

The following tables set forth the outstanding stock awards for the period specified:

 

 

 

Three Months Ended

 

 

Year

Ended

 

 

 

March 30,

2024

 

 

December 30,

2023

 

 

 

Shares

 

 

Shares

 

Outstanding at beginning of period

 

 

89,400

 

 

 

64,500

 

Issued

 

 

-

 

 

 

82,800

 

Exercised

 

 

(23,734)

 

 

(10,600)

Forfeited

 

 

(1,433)

 

 

(47,300)

Outstanding at end of period

 

 

64,233

 

 

 

89,400

 

 

As of March 30, 2024, outstanding SARs and stock awards had an intrinsic value of $2,245,274.

v3.24.1.u1
Share Repurchase Program
3 Months Ended
Mar. 30, 2024
Share Repurchase Program  
Share Repurchase Program

Note I – Share Repurchase Program

 

On August 21, 2023, the Company announced that the Board of Directors of the Company had approved a new share repurchase program authorizing the Company to repurchase up to 200,000 shares of the Company’s common stock through August 20, 2028. The Company’s share repurchase program does not obligate it to acquire the Company’s common stock at any specific cost per share. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

 

Below is a summary of the Company’s shares repurchased during the first quarter of 2024 under the new share repurchase program.

 

Period

 

Total

Number

of Shares

Purchased

 

 

Average

Price Paid

Per Share

 

 

Total

Number

of Shares

Purchased

as Part of

Publicly

Announced

Plans or

Programs

 

 

Maximum

Number

of Shares

that may

yet be

Purchased

Under the

Plans or

Programs

 

Balance as of December 30, 2023

 

 

40,000

 

 

$18.39

 

 

 

40,000

 

 

 

160,000

 

December 31, 2024 – March 30, 2024

 

 

10,076

 

 

 

23.30

 

 

 

10,076

 

 

 

149,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 30, 2024

 

 

50,076

 

 

$19.38

 

 

 

50,076

 

 

 

149,924

 

v3.24.1.u1
Revenue Recognition
3 Months Ended
Mar. 30, 2024
Revenue Recognition  
Revenue Recognition

Note J – Revenue Recognition

 

The Company’s revenues result from the sale of goods and services and reflect the consideration to which the Company expects to be entitled. The Company records revenues in accordance with FASB Accounting Standards Codification (“ASC”) Topic 606, “Revenue from Contracts with Customers.”  The Company has defined purchase orders as contracts in accordance with ASC Topic 606. For its customer contracts, the Company identifies its performance obligations, which are delivering goods or services, determines the transaction price, allocates the contract transaction price to the performance obligations (when applicable), and recognizes the revenue when (or as) the performance obligation is transferred to the customer. A good or service is transferred when the customer obtains control of that good or service. The Company’s revenues are recorded at a point in time from the sale of tangible products. Revenues are recognized when products are shipped.

 

Customer volume rebates, product returns, discount and allowance are variable considerations and are recorded as a reduction of revenue in the same period that the related sales are recorded. The Company has reviewed the overall sales transactions for variable consideration and has determined that these costs are not material.

 

The Company has no future performance obligations and does not capitalize costs to obtain or fulfill contracts.

v3.24.1.u1
Income Taxes
3 Months Ended
Mar. 30, 2024
Income Taxes  
Income Taxes

Note K - Income Taxes

 

The Company files income tax returns in the U.S. federal jurisdiction, and in various states and foreign jurisdictions. With limited exceptions, the Company is no longer subject to U.S. federal, state, and local income tax examinations by tax authorities for years before 2019 and is no longer subject to non-U.S. income tax examinations by foreign tax authorities for years prior to 2017.

 

The total amount of unrecognized tax benefits could increase or decrease within the next 12 months for several reasons, including the closure of federal, state, and foreign tax years by expiration of the statute of limitations and the recognition and measurement considerations under FASB ASC Topic 740, “Income Taxes.”  There have been no significant changes to the value of unrecognized tax benefits during the three months ended March 30, 2024. The Company believes that it is reasonably possible that the total amount of unrecognized tax benefits will not increase or decrease significantly over the next twelve months.

v3.24.1.u1
Retirement Benefit Plans
3 Months Ended
Mar. 30, 2024
Retirement Benefit Plans  
Retirement Benefit Plans

Note L - Retirement Benefit Plans

 

The Company has four non-contributory defined benefit pension plans covering most U.S. employees. All of these pension plans are frozen and participants in these plans have not accrued benefits since the date on which these plans were frozen. Plan benefits are generally based upon age at retirement, years of service and, for the plan covering salaried employees, the level of compensation. The Company also sponsors unfunded non-qualified supplemental retirement plans that provide certain former officers with benefits in excess of limits imposed by federal tax law.

 

The Company also provides health care and life insurance for retired salaried employees in the United States who meet specific eligibility requirements.

 

Significant disclosures relating to these benefit plans for the first quarter of fiscal years 2024 and 2023 are as follows:

 

 

 

Pension Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$178,003

 

 

$216,153

 

Interest cost

 

 

966,702

 

 

 

990,054

 

Expected return on plan assets

 

 

(1,099,035)

 

 

(1,049,016)

Amortization of the net loss

 

 

327,365

 

 

 

342,865

 

Net periodic benefit cost

 

$373,035

 

 

$500,056

 

 

 

 

Other Postretirement Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$3,574

 

 

$6,486

 

Interest cost

 

 

12,951

 

 

 

14,533

 

Expected return on plan assets

 

 

(4,684)

 

 

(4,849)

Amortization of prior service cost

 

 

1,060

 

 

 

1,060

 

Amortization of the net loss

 

 

(19,567)

 

 

(16,895)

Net periodic benefit (gain) cost

 

$(6,666)

 

$335

 

 

The Company’s funding policy with respect to its qualified plans is to contribute at least the minimum amount required by applicable laws and regulations. In fiscal year 2024, the Company expects to make cash contributions to its qualified pension plans of approximately $2,100,000 and approximately $50,000 into its other postretirement plan. As of March 30, 2024, the Company has contributed $450,000 to its pension plans and $7,000 to its postretirement plan and expects to make the remaining contributions as required during the remainder of the fiscal year.

The Company has a contributory savings plan under Section 401(k) of the Internal Revenue Code (the “401(k) Plan”) covering substantially all U.S. non-union employees. The 401(k) Plan allows participants to make voluntary contributions from their annual compensation on a pre-tax basis, subject to limitations under the Internal Revenue Code. The 401(k) Plan provides for contributions by the Company at its discretion.

 

The Company made contributions to the 401(k) Plan as follows:

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Regular matching contribution

 

$285,563

 

 

$252,761

 

Transitional credit contribution

 

 

28,906

 

 

 

34,320

 

Non-discretionary contribution

 

 

110,890

 

 

 

431,950

 

Total contributions for the period

 

$425,359

 

 

$719,031

 

 

The non-discretionary contribution of $328,953 made in the three months ended April 1, 2023, was accrued for, and expensed in the prior fiscal year.

 

Effective January 1, 2023, the non-discretionary contributions are being contributed on a weekly basis.

v3.24.1.u1
Recent Accounting Pronouncements
3 Months Ended
Mar. 30, 2024
Recent Accounting Pronouncements  
Recent Accounting Pronouncements

Note M - Recent Accounting Pronouncements

 

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which amends the reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This standard is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We do not expect this new standard to have a significant impact on our disclosures.

 

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation, (2) the income or loss from continuing operations before income tax expense or benefit disaggregated between domestic and foreign and (3) income tax expense or benefit from continuing operations disaggregated by federal, state, and foreign. The update also requires entities to disclose their income tax payments to various jurisdictions. This standard is effective for fiscal years beginning after December 15, 2024. We do not expect this new standard to have a significant impact on our disclosures.

 

The Company has implemented all new accounting pronouncements that are in effect and that could impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued, but are not yet effective, that might have a material impact on the consolidated financial statements of the Company.

v3.24.1.u1
Concentration of risk
3 Months Ended
Mar. 30, 2024
Concentration of risk  
Concentration of risk

Note N - Concentration of Risk

 

Credit Risk

 

Credit risk is the potential financial loss resulting from the failure of a customer or counterparty to settle its financial and contractual obligations to the Company, as and when they become due. The primary credit risk for the Company is its accounts receivable due from customers. The Company has established credit limits for customers and monitors their balances to mitigate the risk of loss. As of March 30, 2024, there was one significant concentration of credit risk with a customer, who had receivables representing 12% of our net accounts receivable. One single customer represented 12% of the Company’s net accounts receivable as of December 30, 2023. The maximum exposure to credit risk is primarily represented by the carrying amount of the Company’s accounts receivable.

 

The Company has deposits that exceed amounts up to $250,000 that are insured by the Federal Deposit Insurance Corporation (FDIC), but the Company does not consider this a significant concentration of credit risk based on the strength of the financial institution.

Interest Rate Risk

 

The Company’s exposure to the risk of changes in market interest rates relates primarily to the Company’s debt, which bears interest at variable rates based on term SOFR, plus an adjustment of ten basis points, plus an applicable margin of 1.875% to 2.625%, depending on the Company’s senior net leverage ratio.

 

Currency Exchange Rate Risk

 

The Company’s currency exposure is concentrated in the Canadian dollar, Mexican peso, New Taiwan dollar, Chinese RMB, and Hong Kong dollar. Because of the Company’s limited exposure to any single foreign market, any exchange gains or losses have not been material and are not expected to be material in the future. As a result, the Company does not attempt to mitigate its foreign currency exposure through the acquisition of any speculative or leveraged financial instruments.

v3.24.1.u1
Business Acquisition
3 Months Ended
Mar. 30, 2024
Business Acquisition  
Business Acquisition

Note O – Business Acquisition

 

On June 29, 2023, the Company acquired certain assets, including accounts receivable, inventories, furniture, fixtures and equipment, intellectual property rights, and rights existing under all sales and purchase agreements, and assumed certain liabilities of Sureflex, Inc. (“Sureflex”). These assets are held in our Velvac, Inc. (“Velvac”) subsidiary. We expect that Sureflex, which manufactures tractor-trailer electrical connection cable assemblies, will enable the Company to manufacture electrical products and become more competitive with respect to cost and quality.

 

The acquisition of Sureflex was accounted for under Business Combinations (ASC Topic 805). The acquired business is included in the consolidated operating results of the Company from the effective date of the acquisition. The excess of the cost of Sureflex over the fair market value of the net assets acquired of $0.5 million has been recorded as goodwill.

 

Neither the actual results nor the pro forma effects of the Sureflex acquisition are material to the Company’s financial statements.

v3.24.1.u1
Earnings per Share (Tables)
3 Months Ended
Mar. 30, 2024
Earnings per share:  
Schedule of Denominators Used in Earnings Per Share Computations

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Basic:

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

 

 

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

 

 

 

Weighted average shares outstanding

 

 

6,215,673

 

 

 

6,223,027

 

Dilutive stock appreciation rights

 

 

39,727

 

 

 

10,962

 

Denominator for diluted earnings per share

 

 

6,255,400

 

 

 

6,233,989

 

v3.24.1.u1
Inventories (Tables)
3 Months Ended
Mar. 30, 2024
Inventories  
Schedule of Inventories from continuing operations

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

 

 

 

 

 

Raw material and component parts

 

$23,084,312

 

 

$24,500,087

 

Work in process

 

 

9,381,683

 

 

 

9,957,068

 

Finished goods

 

 

23,381,076

 

 

 

24,815,052

 

Total inventories

 

$55,847,071

 

 

$59,272,207

 

v3.24.1.u1
Leases (Tables)
3 Months Ended
Mar. 30, 2024
Leases  
Schedule of Future Minimum Payments Under Non-Cancelable Operating Leases

 

 

Operating

 

 

Finance

 

2024

 

$3.2

 

 

$0.1

 

2025

 

 

3.2

 

 

 

0.2

 

2026

 

 

2.5

 

 

 

0.2

 

2027 and thereafter

 

 

10.2

 

 

 

0.6

 

 

 

 

19.1

 

 

 

1.1

 

Less effects of discounting

 

 

(2.6)

 

 

(0.2)

Lease liabilities recognized

 

$16.5

 

 

$0.9

 

v3.24.1.u1
Stock Options and awards (Tables)
3 Months Ended
Mar. 30, 2024
Stock Options and awards  
Schedule of Stock Appreciation Rights Activity

 

 

Three Months Ended

 

 

Year Ended

 

 

 

March 30, 2024

 

 

December 30, 2023

 

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

 

Units

 

 

Weighted

Average

Exercise

Price

 

Outstanding at beginning of period

 

 

13,000

 

 

$24.19

 

 

 

146,166

 

 

$23.22

 

Expired

 

 

(9,000)

 

 

26.30

 

 

 

(50,833)

 

 

24.24

 

Exercised

 

 

-

 

 

 

-

 

 

 

(33,333)

 

 

21.10

 

Forfeited

 

 

-

 

 

 

-

 

 

 

(49,000)

 

 

22.80

 

Outstanding at end of period

 

 

4,000

 

 

$

20.20

 

 

 

13,000

 

 

$

24.19

 

Schedule of SARs Outstanding and Exercisable

SARs Outstanding and Exercisable

 

 

 

 

 

 

 

 

 

 

 

Range of Exercise Prices

 

 

Outstanding as

of March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted

Average

Exercise

Price

 

 

Exercisable

as of

March 30,

2024

 

 

Weighted

Average

Remaining

Contractual

Life

 

 

Weighted Average Exercise Price

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

 

 

4,000

 

 

 

1.1

 

 

$20.20

 

Schedule of Outstanding Stock Grants

 

 

Three Months Ended

 

 

Year

Ended

 

 

 

March 30,

2024

 

 

December 30,

2023

 

 

 

Shares

 

 

Shares

 

Outstanding at beginning of period

 

 

89,400

 

 

 

64,500

 

Issued

 

 

-

 

 

 

82,800

 

Exercised

 

 

(23,734)

 

 

(10,600)

Forfeited

 

 

(1,433)

 

 

(47,300)

Outstanding at end of period

 

 

64,233

 

 

 

89,400

 

v3.24.1.u1
Share Repurchase Program (Tables)
3 Months Ended
Mar. 30, 2024
Share Repurchase Program  
Schedule of Company's shares repurchased

Period

 

Total

Number

of Shares

Purchased

 

 

Average

Price Paid

Per Share

 

 

Total

Number

of Shares

Purchased

as Part of

Publicly

Announced

Plans or

Programs

 

 

Maximum

Number

of Shares

that may

yet be

Purchased

Under the

Plans or

Programs

 

Balance as of December 30, 2023

 

 

40,000

 

 

$18.39

 

 

 

40,000

 

 

 

160,000

 

December 31, 2024 – March 30, 2024

 

 

10,076

 

 

 

23.30

 

 

 

10,076

 

 

 

149,924

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 30, 2024

 

 

50,076

 

 

$19.38

 

 

 

50,076

 

 

 

149,924

 

v3.24.1.u1
Retirement Benefit Plans (Tables)
3 Months Ended
Mar. 30, 2024
Retirement Benefit Plans  
Schedule of Significant Disclosures Relating to Benefit Plans

 

 

Pension Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$178,003

 

 

$216,153

 

Interest cost

 

 

966,702

 

 

 

990,054

 

Expected return on plan assets

 

 

(1,099,035)

 

 

(1,049,016)

Amortization of the net loss

 

 

327,365

 

 

 

342,865

 

Net periodic benefit cost

 

$373,035

 

 

$500,056

 

 

 

Other Postretirement Benefits

 

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Service cost

 

$3,574

 

 

$6,486

 

Interest cost

 

 

12,951

 

 

 

14,533

 

Expected return on plan assets

 

 

(4,684)

 

 

(4,849)

Amortization of prior service cost

 

 

1,060

 

 

 

1,060

 

Amortization of the net loss

 

 

(19,567)

 

 

(16,895)

Net periodic benefit (gain) cost

 

$(6,666)

 

$335

 

Schedule of Company made contributions towards benefit plans

 

 

Three Months Ended

 

 

 

March 30, 2024

 

 

April 1, 2023

 

Regular matching contribution

 

$285,563

 

 

$252,761

 

Transitional credit contribution

 

 

28,906

 

 

 

34,320

 

Non-discretionary contribution

 

 

110,890

 

 

 

431,950

 

Total contributions for the period

 

$425,359

 

 

$719,031

 

v3.24.1.u1
Earnings Per Share (Details) - shares
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Earnings per share:    
Weighted Average Shares Outstanding 6,215,673 6,223,027
Diluted [abstract]    
Weighted Average Shares Outstanding 6,215,673 6,223,027
Dilutive Stock Appreciation Rights 39,727 10,962
Denominator For Diluted Earnings Per Share (in Shares) 6,255,400 6,233,989
v3.24.1.u1
Inventories (Details) - USD ($)
Mar. 30, 2024
Dec. 30, 2023
Inventories    
Raw Material And Component Parts $ 23,084,312 $ 24,500,087
Work In Process 9,381,683 9,957,068
Finished Goods 23,381,076 24,815,052
Total Inventories $ 55,847,071 $ 59,272,207
v3.24.1.u1
Goodwill (Details Narrative)
$ in Millions
Mar. 30, 2024
USD ($)
Goodwill  
Aggregate carrying amount of goodwill $ 70.7
v3.24.1.u1
Leases (Details)
$ in Millions
Mar. 30, 2024
USD ($)
Leases  
2024 operating lease $ 3.2
2025 operating lease 3.2
2026 operating lease 2.5
2027 operating lease and thereafter 10.2
Operating Leases, Future Minimum Payments Due gross 19.1
Less effects of discounting OperatingLeases (2.6)
Lease liabilities recognized Operating Leases 16.5
2024 Finance lease 0.1
2025 finance lease 0.2
2026 finance lease 0.2
2027 financ lease and thereafter 0.6
Finance Leases, Future Minimum Payments Due gross 1.1
Less effects of discounting Finance Leases (0.2)
Lease liabilities recognized financing Leases $ 0.9
v3.24.1.u1
Leases (Details Narrative)
$ in Millions
3 Months Ended
Mar. 30, 2024
USD ($)
Leases  
Operating lease liabilities $ 16.5
Finance lease liabilities $ 0.9
Weighted average lease term for operating leases 7 years
Weighted average lease term for finance leases 5 years 9 months 18 days
Weighted average discount rate operating leases 6.30%
Weighted average discount rate finance leases 6.40%
v3.24.1.u1
Debt (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Jun. 16, 2023
Mar. 30, 2024
Credit Agreement [Member]    
Ratio Description   applicable margin of 1.875% to 2.625%, with such margins determined based on the Company’s senior net leverage ratio. The Company’s obligations under the Credit Agreement are secured by a lien on certain of the Company’s and its subsidiaries’ assets pursuant to a Pledge and Security Agreement
Line Of Credit Member [Member]    
Annual Commitment Fee Percentage 0.30%  
Medium Term Notes [Member] | September 30, 2023 through June 30, 2025 [Member]    
Quarterly Principal Payment   $ 750,000
Medium Term Notes [Member] | September 30, 2025 through June 30, 2027 [Member]    
Quarterly Principal Payment   1,125,000
Medium Term Notes [Member] | September 30, 2027 through March 31, 2028 [Member]    
Quarterly Principal Payment   $ 1,500,000
Medium Term Notes [Member] | Interest Rate Swap [Member]    
Term portion loan $ 60,000,000  
Revolving Commitment Portion $ 30,000,000  
Minimum [Member] | Medium Term Notes [Member]    
Variable Interest Rate Based On Senior Net Leverage Ratio   0.87%
Maximum [Member] | Medium Term Notes [Member]    
Variable Interest Rate Based On Senior Net Leverage Ratio   1.62%
v3.24.1.u1
Stock Options and awards (Details) - Stcok Options [Member] - $ / shares
3 Months Ended 12 Months Ended
Mar. 30, 2024
Mar. 30, 2024
Dec. 30, 2023
Number of units outstanding at beginning of period 13,000 13,000 146,166
Number of units, Expired   (9,000) (50,833)
Number of units, Exercised   0 (33,333)
Number of units, Forfeited   0 (49,000)
Number of units outstanding at end of period 4,000 4,000 13,000
Weighted average exercise price, beginning balance   $ 24.19 $ 23.22
Weighted average exercise price, Expired   26.30 24.24
Weighted average exercise price, exercised   0 21.10
Weighted average exercise price, forfeited   0 22.80
Weighted average exercise price, ending balance $ 20.20 $ 20.20 $ 24.19
v3.24.1.u1
Stock Options and awards (Details 1)
3 Months Ended
Mar. 30, 2024
$ / shares
shares
Outstanding | shares 4,000
Exercisable | shares 4,000
Range of Exercise Prices (in dollar per share) $ 20.20
Maximum [Member] | SAR [Member]  
Weighted- Average Remaining Contractual Life 1 year 1 month 6 days
Weighted avaerage exercise price $ 20.20
Minimum [Member] | SAR [Member]  
Weighted- Average Remaining Contractual Life 1 year 1 month 6 days
Weighted avaerage exercise price $ 20.20
v3.24.1.u1
Stock Options and awards (Details 2) - Stock Options [Member] - shares
3 Months Ended 12 Months Ended
Mar. 30, 2024
Dec. 30, 2023
Number of units outstanding at beginning of period 89,400 64,500
Issued   82,800
Number of units, Exercised (23,734) (10,600)
Number of units, Forfeited (1,433) (47,300)
Number of units outstanding at end of period 64,233 89,400
v3.24.1.u1
Stock Options and awards (Details Narrative) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Stock compensation expense $ 434,000 $ 184,000
Intrinsic value $ 2,245,274  
2020 Plan [Member]    
Stock Option Granted 879,924  
v3.24.1.u1
Share Repurchase Program (Details)
3 Months Ended
Mar. 30, 2024
$ / shares
shares
Maximum Number of Shares That May Yet be Purchased Under the Plans or Programs [Member]  
Maximum Number Of Shares That May Yet Be Purchased Under The Plans Or Programs, Beginning Balance 160,000
Maximum Number Of Shares That May Yet Be Purchased Under The Plans Or Programs 149,924
Maximum Number Of Shares That May Yet Be Purchased Under The Plans Or Programs, Ending Balance 149,924
Average Price Paid Per Share [Member]  
Average Price Paid Per Share, Beginning Balance | $ / shares $ 18.39
Average Price Paid Per Share During The Period | $ / shares 23.30
Average Price Paid Per Share, Ending Balance | $ / shares $ 19.38
Total Number of Shares Purchased [Member]  
Total Number Of Shares Purchased, Beginning Balance 40,000
Total Number Of Shares Purchased 50,076
Total Number Of Shares Purchased,ending Balance 10,076
Total Number of Shares Purchased As Part of Publicly Announced Plansor Programs [Member]  
Total Number Of Shares Purchased As Part Of Publicly Announced Plansor Programs, Beginning Balance 40,000
Total Number Of Shares Purchased As Part Of Publicly Announced Plansor Programs 10,076
Total Number Of Shares Purchased As Part Of Publicly Announced Plansor Programs, Ending Balance 50,076
v3.24.1.u1
Share Repurchase Program (Details Narrative)
Aug. 21, 2023
shares
Share Repurchase Program  
Number Of Shares Authorized To Be Repurchased 200,000
v3.24.1.u1
Retirement Benefit Plans (Details 1) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Total contributions for the period $ 425,359 $ 719,031
Regular Matching Contributions [Member]    
Total contributions for the period 285,563 252,761
Transitional Credit Contributions [Member]    
Total contributions for the period 28,906 34,320
Non-Discretionary Contributions [Member]    
Total contributions for the period $ 110,890 $ 431,950
v3.24.1.u1
Retirement Benefit Plans (Details) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Pension Benefit [Member]    
Service cost $ 178,003 $ 216,153
Interest cost 966,702 990,054
Expected return on plan assets (1,099,035) (1,049,016)
Amortization of the net loss 327,365 342,865
Net periodic benefit cost 373,035 500,056
Other Postretirement Benefit [Member]    
Service cost 3,574 6,486
Interest cost 12,951 14,533
Expected return on plan assets (4,684) (4,849)
Amortization of prior service cost 1,060 1,060
Amortization of the net loss (19,567) (16,895)
Net periodic benefit cost $ (6,666) $ 335
v3.24.1.u1
Retirement Benefit Plans (Details Narrative) - USD ($)
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Accrued amount for non discretionary safe harbor contribution   $ 328,953
Pension Benefit [Member]    
2024 $ 210,000,000,000  
Cash contributions 50,000  
Other Postretirement Benefit [Member]    
2024 450,000  
Cash contributions $ 7,000  
v3.24.1.u1
Concentration of risk (Details Narrative)
3 Months Ended
Mar. 30, 2024
USD ($)
Federal Deposit Insurance Corporation (FDIC) $ 250,000
Minimum [Member] | Line Of Credit Member [Member] | LIBOR [Member]  
Basis spread on variable rate 1.87%
Maximum [Member] | Line Of Credit Member [Member] | LIBOR [Member]  
Basis spread on variable rate 2.62%
Accounts Receivable [Member] | Customer Concentration Risk [Member]  
Threshold percentage of concentration risk 12.00%
v3.24.1.u1
Business Acquisition (Details Narrative)
$ in Millions
Mar. 30, 2024
USD ($)
Business Acquisition  
Goodwill $ 0.5

Eastern (NASDAQ:EML)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Eastern
Eastern (NASDAQ:EML)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Eastern